The fibroblast growth factor receptor 3 (FGFR3) plays a critical role in the regulation of endochondral ossification. Fgfr3 gain-of-function mutations cause achondroplasia, the most common form of dwarfism, and a spectrum of chondrodysplasias. Despite a significant number of studies on the role of FGFR3 in cartilage, to date, none has investigated the influence of Fgfr3-mediated effects of the growth plate on bone formation. We studied three mouse models, each expressing Fgfr3 mutation either ubiquitously (CMV-Fgfr3
INTRODUCTION
The fibroblast growth factor receptors 3 (FGFR3) plays a critical role in the development of the skeleton (1) . Mutations in FGFR3 gene have been linked to skeletal dysplasias and craniosynostosis. Most FGFR3 gain-of-function mutations are responsible for a family of chondrodysplasias characterized by rhizomelic dwarfism, narrow trunk and macrocephaly. Achondroplasia (ACH) is the most common form (2 -5) , hypochondroplasia (6) is a milder form and thanatophoric dysplasia (TD) is lethal (7) . Two distinct recurrent FGFR3 mutations are responsible for two craniosynostoses; Muenke (8) and Crouzon with acanthosis nigricans syndrome, respectively (9) .
Endochondral ossification consists in the formation of a cartilage template followed by its replacement by bone (10) . In the growth plate, chondrocytes proliferate and gradually undergo hypertrophy, modifying their surrounding extracellular matrix by expressing collagen type X (Col X) and alkaline phosphatase (ALP). Hypertrophic chondrocytes secrete angiogenic factors such as Vegfa (11) , thus inducing sprouting angiogenesis from the perichondrium. The calcified cartilage removed by osteoclasts and Mmps (metalloproteinases) (12) (13) (14) is replaced by bone tissue synthesized by osteoblasts (10) .
Numerous growth factors and hormones expressed by pre/ hypertrophic chondrocytes control both chondrogenesis and osteogenesis such as Indian hedgehog (Ihh) (15, 16) , parathyroid hormone-related protein (PTHrP) (17, 18) , bone morphogenetic proteins (BMPs) (19) and FGFRs (20) .
In the long bone, FGFR3 is strongly expressed in proliferative and prehypertrophic chondrocytes and in mature osteoblasts (20) (21) (22) . Several Fgfr3 mouse models have demonstrated the role of Fgfr3 on the growth plate and bone remodeling at adult age (23) (24) (25) . Our recent study of Fgfr3 Y367C/+ mice expressing a TD mutation showed the severe disorganization of the growth plate, premature cell cycle arrest and defective chondrocyte differentiation (26) (27) (28) . The role of Fgfr3 in bone remodeling was suggested from adult Fgfr3 knock-out and knock-in mice Fgfr3 Y3697C ; these two mouse models showed osteopenia and defects in bone matrix mineralization (25, 29, 30) . However, the role of Fgfr3 in bone modeling is poorly understood during growth.
In order to decipher the impact of activating mutations of Fgfr3 on bone modeling, we studied three mouse models at 3 weeks of age, which expressed the TD point mutation either ubiquitously, in the cartilage or in the bone. The two mouse models expressing activated Fgfr3 in the cartilage displayed dwarfism, whereas Fgfr3 expression restricted to bone induced no obvious phenotype. In dwarf mice, microscanner and histomorphometric analysis revealed dramatic defects in the primary ossification and in the secondary spongiosa (trabecular bone).
Here, we demonstrate that the expression of an Fgfr3-activating mutation in the cartilage is sufficient to induce disorganization of the growth plate and bone defects. We conclude that activated Fgfr3 disturbs bone modeling via a paracrine mechanism.
RESULTS
The skeletal phenotype is dependent on the local or ubiquitous expression of mutant Fgfr3
We compared mice expressing an Fgfr3-activating point mutation ubiquitously, in chondrocytes or in differentiated osteoblasts by crossing Fgfr3 neoY367C/+ mice (27) with CMV-Cre (31), Col2a1-Cre (32) and Col1a1-Cre (33), respectively. The mutated allele was visualized by genomic polymerase chain reaction (PCR) only in expected tissues (Fig. 1A) .
At 3 weeks of age, CMV-Fgfr3 Y367C/+ mice exhibited a severe dwarfism characterized by a dome-shaped skull, a narrow trunk, short ribs and long bones (Fig. 1B) . Interestingly, X-ray analysis indicated that Col II-Fgfr3 Y367C/+ mice had a less severe phenotype with a moderate dome-shaped skull compared with CMV-Fgfr3 Y367C/+ mice (Fig. 1B) . In contrast, Col I-Fgfr3 Y367C/+ mice displayed no obvious skeletal phenotype (Fig. 1B) .
Dwarfism was confirmed by morphometric measurements (Table 1) (Fig. 1Ca  and b) . The growth plates exhibited obvious abnormalities with a lack of proliferative column organization, reduced proliferative and hypertrophic areas and small hypertrophic cells ( Fig. 1Da and b) . Col I-Fgfr3 Y367C/+ mice did not display abnormalities of the growth plate ( Fig. 1C and D) . The expression of the activated receptor in the cartilage led to severe chondrodysplasias mimicking ACH, while its expression restricted to osteoblasts did not disturb bone growth.
Expression of an activating Fgfr3 mutation in the cartilage induces significant primary spongiosa abnormalities
To understand the long bone ossification process in Fgfr3-related chondrodysplasias, we first focused our attention on the calcified cartilage and the primary spongiosa (precursor of the trabecular bone). Histological analyses of these two areas, after Von Kossa/Van Gieson staining, showed a defect in mineralization with a smaller hypertrophic mineralized zone in CMV-Fgfr3 Y367C/+ and Col II-Fgfr3 Y367C/+ mice ( Fig. 2A, B and D) . The subchondral trabeculae were fewer and partially mineralized compared with Fgfr3 +/+ mice ( Fig. 2A, B and D) . We observed more abundant collagen deposition in subchondral trabeculae using Alcian blue/Van Gieson staining (Fig. 2E, F and H) . Interestingly, no defect in the primary spongiosa was observed in Col I-Fgfr3 Y367C/+ mice ( Fig. 2C and G) .
To evaluate whether these alterations of bone modeling resulted from defects of matrix degradation and/or osteoblast function, we examined expression of cartilage and bone markers by ISH. A severe defect of chondrocyte differentiation in human ACH and mutant Fgfr3 mouse models has been described previously (28, (34) (35) (36) (37) . Here, we detected the same defect revealed by a decrease in Col X expression only in CMV-Fgfr3 Y367C/+ and Col II-Fgfr3 Y367C/+ mice ( Fig. 3A -D) . Cartilage resorption is regulated by several factors, among them Mmp13, which is secreted by hypertrophic and by osteoblastic cells at the chondro-osseous junction. In CMV-Fgfr3 Y367C/+ and Col II-Fgfr3 Y367C/+ mice, its expression was unchanged in hypertrophic cells and reduced in the primary spongiosa compared with controls ( Fig. 3E -H Y367C/+ and Col II -Fgfr3 Y367C/+ mice was disorganized with anomalies of proliferative columns organization and a reduction in the height of proliferative and hypertrophic zones (P, proliferative zone; H, hypertrophic zone). 
Body without tail length (mm) 68.9 + 1. osteoclast adhesion, exhibited no obvious change in each mouse model ( Fig. 3M -P) .
To test whether the abnormalities seen in the primary spongiosa of CMV-Fgfr3 Y367C/+ and Col II-Fgfr3 Y367C/+ mice could be due in part to a defect of osteoclasts, we measured the number of tartrate-resistant acid phosphatase (TRAP)-positive cells in the primary spongiosa (Fig. 4A) . Histomorphometric analysis demonstrated that the proportion of total osteoclasts per bone area and the ratio of the osteoclast surface to the bone surface were significantly higher in these mice than in their control littermates ( Fig. 4B and C) . These results showed an increase in osteoclast recruitment in the primary spongiosa of the CMV-Fgfr3 Y367C/+ and Col II-Fgfr3 Y367C/+ mice.
Defects of bone remodeling in the secondary spongiosa result from altered Fgfr3 function in the cartilage
In order to estimate whether the defect observed in the primary spongiosa affects also the secondary spongiosa, we quantified structural parameters of the trabecular bone in the distal metaphysis of the femurs in the three mouse models by microcomputed tomography (CT). Three-dimensional (3D) reconstructions ( Fig. 5A ) of CMV-Fgfr3 Y367C/+ femora allowed us to identify significant defects in bone morphology, i.e. a reduction in bone length and width, and anomalies in the trabecular bone. Quantitative analyses revealed that CMV-Fgfr3 Y367C/+ mice have a significantly lower BV/TV compared with controls. The trabecular structure and network were affected since Tb.Th. and Tb.N. were decreased compared with CMV-Fgfr3 +/+ mice (Table 2) . Moreover, a significant increase in the structure model index (SMI) indicated a reduction in plate-like structures (Table 2 ). These data were confirmed by histomorphometric analysis (Fig. 5B) .
Micro-CT analysis were performed for Col II-Fgfr3 Y367C/+ mice and revealed the same bone morphology as CMV-Fgfr3 Y367C/+ (Fig. 6A and Table 2 ). These results were consistent with histomorphometric analysis (Fig. 6B) . In addition, we observed a decrease in femur width in the two mouse models due to a decrease in cortical thickness and a decrease in internal diaphysis diameter (Table 2) .
Micro-CT analysis of Col I-Fgfr3 Y367C/+ femora revealed no defect in the structure and volume of the trabecular bone (Supplementary Material, Fig. S2 and Table S1 ). These results indicated that the main defects of the secondary spongiosa in 3-week-old CMV-Fgfr3 Y367C/+ and Col II-Fgfr3 Y367C/ + mice were due to the effect of the activating Fgfr3 mutation in the cartilage.
DISCUSSION
FGFR3 is an important mediator of chondrocyte function during endochondral bone development and osteoblast function during intramembranous bone development (1). +/+ : * P ≤ 0.01, * * P ≤ 0.001, * * * P ≤ 10 24 and * * * * P ≤ 10
This tyrosine kinase receptor is expressed in chondrocytes and mature osteoblasts (20 -22) . FGFR3 mutations cause chondrodysplasias and craniosynostosis and severely affect endochondral and membranous ossification, respectively. In two craniosynostoses, Muenke (8) and Crouzon with acanthosis nigricans syndrome (9, 38) , membranous ossification is disturbed. In FGFR3-related chondrodysplasias, endochondral ossification is severely affected. The defect of the growth plate is correlated with the severity of the phenotype (37) .
Despite a significant number of studies on the role of FGFR3 in the cartilage, none has investigated the influence of the growth plate on bone formation. In a murine model of Muenke syndrome, mutant mice (Fgfr3 P244R ) exhibit anomalies of the premaxillary and zygomatic sutures, a decrease in cortical thickness and bone mineral density in long bones (39) and a defect in perichondrial ossification (40) . In a mouse model of chondrodysplasia, one study suggested a role for Fgfr3 during long bone remodeling (25) . The authors demonstrated that a ubiquitous gain-of-function mutation in Fgfr3 adult mice leads to a decrease in bone mass, as illustrated by a reduction in trabecular bone volume and bone mineral density. Additionally, adult mice lacking functional Fgfr3 or Fgfr3 IIIc showed osteopenia and defects in bone matrix mineralization (29, 30) . In young Fgfr3 G369C/+ mice, variable expression of osteoblast markers has also been observed (24) . These studies allow us to conclude that mutant Fgfr3 directly disturbs osteoblasts and osteoclasts, but they do not explore the potential impact of the growth plate on bone modeling.
In order to discriminate the specific roles of Fgfr3 in the cartilage and bone during post-natal bone development, we analyzed three relevant Fgfr3 mouse models at 3 weeks of age, which expressed one Fgfr3-activating point mutation either ubiquitously, in the cartilage or in differentiated osteoblasts. Here, the Col I-Fgfr3 Y367C/+ mice did not display a skeletal phenotype, whereas CMV-Fgfr3 Y367C/+ and Col II-Fgfr3 Y367C/+ mice exhibited dwarfism and mimicked ACH phenotype. These phenotypes were consistent with the other Fgfr3 mouse models where expression of an Fgfr3-activating mutation in proliferative chondrocytes was sufficient to induce endochondral ossification anomalies (34, 36) .
While long bone development involves endochondral ossification, craniofacial development is dependent on both endochondral and membranous ossifications.
The CMV-Fgfr3 Y367C/+ mouse model exhibited a dome-shaped skull, while the Col II-Fgfr3
Y367C/+ mouse model exhibited a more moderate skull phenotype. These data suggest that ubiquitous expression of the Fgfr3-activating mutation might affect both membranous and endochondral ossification processes. The absence of a dome-shaped skull in Col I-Fgfr3 Y367C/+ mice led us to conclude that the impact of the Fgfr3-activating mutation on membranous ossification is minor.
In CMV-Fgfr3 Y367C/+ and Col II-Fgfr3 Y367C/+ mice, endochondral ossification was severely disturbed. Similarly, the growth plate was reduced with a narrower hypertrophic zone associated with a decrease in Col X-positive cells, whereas Mmp13 expression did not vary. In previous work, we demonstrated that ubiquitous Fgfr3-activating mutations promoted abnormal chondrocyte maturation during the ante-natal period (28) . In accordance with these data, we observed the same defect in the growth plate of CMV-Fgfr3 Y367C/+ and Col II-Fgfr3 Y367C/+ mice during the post-natal period. Studying bone formation, we observed a significant reduction in cartilage matrix mineralization and a strong decrease in the bone volume at the primary spongiosa in CMV-Fgfr3 Y367C/+ and Col II-Fgfr3 Y367C/+ mice. In Col I-Fgfr3 Y367C/+ mice, trabecular bone modeling was unchanged compared with controls. In the primary spongiosa, we observed that expression of Col I and Mmp 13 was much lower in CMV-Fgfr3 Y367C/+ and Col 
II-Fgfr3
Y367C/+ mice compared with Col I-Fgfr3 Y367C/+ and control mice. Trabecular bone volume was also decreased as shown by severe osteopenia detected by micro-CT and histomorphometry. In addition, the measurement of the osteoclast number and surfaces in the same area indicated that bone resorption is significantly higher in CMV-Fgfr3 Y367C/+ and Col II-Fgfr3 Y367C/+ mice than in control mice. These results might further suggest a reduced capacity of bone modeling leading to a decrease in new bone formation. Previously, an Fgfr3 G369C/+ mouse model showed reduced trabecular bone volume and bone mineral density at 2 months of age. The authors concluded that Fgfr3 had a direct role on osteoblast proliferation and differentiation and on osteoclast activity (25) . In our study, we excluded a potential function of Fgfr3 on osteoblasts at 3 weeks of age. Indeed, the absence of the phenotype in Col I-Fgfr3 Y367C/+ mice and the normal proliferation and differentiation of primary osteoblasts from CMV-Fgfr3 Y367C/+ calvaria confirmed this hypothesis. During endochondral bone development, hypertrophic chondrocytes play a key role in primary spongiosa formation. They induce ectopic bone formation in adjacent tissues through secreted factors or cell -cell interactions (41, 42) . Moreover, the hypertrophic chondrocytes are responsible for vascular invasion. This replacement of the avascular cartilage template by highly vascularized tissue is a key event of primary spongiosa formation. Among the mediators of angiogenesis, Vegf, a positive regulator, appeared up-regulated in CMV-Fgfr3 Y367C/+ mice, demonstrating that angiogenesis is certainly activated (26) .These data are in accordance with the great reduction in Vegf in Fgfr3 knock-out mice (43). We previously described that angiogenesis in the epiphyseal cartilage is disturbed as shown by the delayed occurrence of the secondary ossification center in CMV-Fgfr3 Y367C/+ mice (26). Here, a delay was also observed in Col II-Fgfr3 Y367C/+ mice, suggesting that angiogenesis might be directly influenced by expression of mutant Fgfr3 in the cartilage.
Other factors expressed by hypertrophic chondrocytes are involved in primary spongiosa formation such as BMPs (44) and the Ihh/PTHrp (15, 42, 45) . Indeed, the dysregulation of hypertrophy in mice lacking PTHrP or its receptor induces ectopic primary spongiosa formation in tissues adjacent to the ectopic hypertrophic cells (18) . In previous studies, constitutive activation of Fgfr3 induced a decrease in Ihh, PTHrP and BMP4 (34, 35) . We hypothesize that dysregulation of Fgfr3 impairs terminal differentiation of chondrocytes and disturbs signaling pathways from chondrocytes to bone cells.
The defect of primary spongiosa in our study could also be explained by the increase in osteoclast recruitment in CMV-Fgfr3 Y367C/+ and Col II-Fgfr3 Y367C/+ mice, and these data confirm the previous finding that FGF signaling enhances osteoclast recruitment (46) . Here, the presence of Op in the primary spongiosa is consistent with the increase in osteoclast attachment to the bone matrix of CMV-Fgfr3 Y367C/+ and Col II-Fgfr3 Y367C/+ mice. Altogether, the severe defect of bone structure and volume in both the primary and the secondary spongiosa in mutant Fgfr3 dwarf mice (CMV-Fgfr3
and Col II-Fgfr3 Y367C/+ ) and the absence of a bone phenotype in Col I-Fgfr3 Y367C/+ mice indicate that the primary spongiosa defect is due to cartilage abnormalities.
In conclusion, despite a significant number of studies that have detailed the role of Fgfr3 in the cartilage, none of them have described the influence of Fgfr3-mediated effects of the growth plate on bone formation. Here, we propose a model in which Fgfr3 mutations and their downstream signaling consequences disturb bone modeling by a paracrine mechanism. This work redefines our understanding of endochondral ossification in FGFR3-related chondrodysplasias and may contribute to research into a future clinical trial of ACH and bone disorders.
MATERIALS AND METHODS

Ethics statement
All experimental procedures and protocols were approved by the French Animal Care and Use Committee.
Fgfr3 mouse models
By crosses with three different Cre lines, we generated three mouse models that express the Y367C mutation (Fgfr3 neoY367C ) (27) either ubiquitously (CMV-Cre mice) (31), in osteochondroprogenitors and chondrocytes (Col2a1-Cre mice) (32) or in mature osteoblasts (Col1a1-Cre mice) (33) . Each experiment was performed on males at 3 weeks of age. Three (Cre-Fgfr3 +/+ ) controls corresponding to each mouse line were analyzed. The Cre lines were maintained in C57/BL6J strain. All the mice were genotyped by PCR of tail DNA as described previously (27) .
Histology and histomorphometric analysis
Femurs were dissected and stored in 70% ethanol at 48C and post-fixed in 90% ethanol, cleared in xylene at 48C and embedded without demineralization in methyl methacrylate. Five micrometer-thick sections were cut parallel to the long axis of the femur using an SM2500S microtome (Leica, Germany). Von Kossa/Van Gieson and Alcian blue/Van Gieson stainings were performed on three non-consecutive sections.
Two non-consecutive sections were stained for TRAP activity (Sigma, St Louis, France) as described previously (47) Other sections were stained with Toluidine Blue to evaluate bone formation parameters or with Aniline Blue for static parameters. Bone parameters were measured on 200 mm for CMV-Fgfr3 Y367C/+ and Col II-Fgfr3 Y367C/+ mice and on 400 mm for Col I-Fgfr3 Y367C/+ and control mice at a standard point below the primary spongiosa.
The histomorphometric parameters were measured within the standard sampling area, following the recommendation of the American Society for Bone and Mineral Research Histomorphometry Nomenclature Committee (48) . Trabecular bone volume (BV/TV), trabecular thickness (Tb.Th.), trabecular number (Tr.N.) and trabecular separation (Tb.Sp.) were measured using the software package developed for bone histomorphometry (Microvision, Evry, France) as described previously (47) .
The number of osteoclasts per bone area (N.Oc/B.Ar; #/mm 2 ) as well as osteoclast surfaces (Oc.S/BS; %) were measured in TRAP-stained sections, using a Leitz integrateplatte II eyepiece at ×128 magnification.
Micro-CT analysis
Three-dimensional microarchitecture of the distal femur was evaluated using a high-resolution SkyScan1076 microtomographic imaging system (SkyScan, Belgium). Images were acquired at 48 KeV, 200 mA and with a 0.5 mm aluminum filter. Three-dimensional reconstructions (8.8 mm cubic resolution) were generated using NRecon software (SkyScan). The femur length was measured between the femur neck and the distal epiphysis. The BV/TV of the metaphysis, Tb.Th., Tb.N and SMI were measured using CTan sofware (skyscan) on a set of sections located within the secondary spongiosa under the growth plate. The measured volume was chosen to be proportional to the femur length (typically 350 mm for control animals and 175 mm for mutant CMV-Fgfr3 Y367C/+ and Col II-Fgfr3 Y367C/+ ). Cortical thickness was calculated by averaging the value obtained on a set of 30 transverse sections located at mid-shaft.
Osteoblast cultures
A primary culture of mouse osteoblastic cells was obtained by sequential collagenase IV (Sigma-Aldrich) digestion of calvaria from 2-to 5-day-old mice. Cells were expanded in T75 flasks (BD Falcon) until subconfluence in an minimum essential medium alpha (Invitrogen) supplemented with 10% fetal calf serum, 2 mM glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin and then harvested with trypsin/ethylenediaminetetraacetic acid (EDTA) (Invitrogen) and plated at a density of 12 500 cells/cm 2 . For proliferation studies [ 3 H]thymidine was added at a concentration of 10 mCi/ml and incubated for 16 h. The cells were harvested on a glass fiber filter paper and assayed for radioactivity by liquid scintillation counting. We used Top Count Microplates scintillation counter (Perkin Elmer). For differentiation studies, we used a differentiation medium with 50 mg/ml ascorbic acid and 10 mM glycerol 2 phosphate di sodium salt hydrate (SigmaAldrich).
In situ hybridization
Femurs were fixed overnight in 4% paraformaldehyde at 48C, decalcified in a 0.5 M EDTA, pH 8.0 solution for 3 weeks and embedded in paraffin. Serial sections of 4 mm were stained with hematoxylin -eosin or were subjected to in situ hybridization (ISH). [S 35 ]-UTP-labeled antisense riboprobes were generated as previously described (49) for detection of expression of the following markers: Col X, osteocalcin (Oc), osteopontin (OP), Col I and Mmp13. An Olympus PD70-IX2-UCB microscope was used for transmitted light examination.
Quantitative PCR analysis
Purified RNA from calvaria primary osteoblasts cultured for 7 and 14 days was isolated using the Qiagen RNeasy Mini kit following the manufacturer's instructions (Qiagen). Five hundred micrograms of each RNA were converted into cDNA using the SuperScript III First-Strand (Invitrogen). Quantitative real-time PCR expression analysis was performed using a 7300 (Applied Biosystem) and ABsolute SYBR Green ROX mix (ABgene). 
Statistical analysis
Differences between experimental groups were assessed using analysis of variance (ANOVA). The significance threshold was set at P ≤ 0.05. All values are shown as mean + SEM. Quantitative PCR experiments were performed three times.
